Ideas to action: independent research for global prosperity
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
CGD NOTES
May 31, 2024
CGD NOTES
June 05, 2024
CGD NOTES
May 23, 2024
WORKING PAPERS
June 05, 2024
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
CGD NOTES
May 14, 2024
This note presents two scenarios for the world economy and development prospects to 2050 based on the forecasting exercises and analysis presented in a series of papers by Philip Adom, Augustin Kwasi Fosu, Dede Woade Gafa, Zack Gehan, Brian Webster, Ranil Dissanayake and Charles Kenny.
CGD NOTES
February 20, 2024
An increasing proportion of official development assistance (ODA) is being dedicated to climate, and climate mitigation in particular. Even were that spending highly effective, and despite reaching about $30 billion in 2020, it is not large enough to finance investment that would significantly slow ...
CGD NOTES
December 06, 2023
Marginal abatement cost curves, which suggest the cheapest approaches to reducing carbon emissions, are out of favor in international climate finance discussions because they are not good tools to use when thinking about systemic and urgent change. On the other hand, international financing studies ...
CGD NOTES
June 07, 2023
PM-JAY, India’s national health insurance program, is the largest publicly funded health insurance program in the world. It has reformed the way in which the poor and vulnerable access hospital care in India. The size of this program and the inclusion of private providers in delivering care has led ...
CGD NOTES
March 09, 2023
High-income countries trying to reach net-zero targets are confronting the fact that existing environmental regulations make it harder to build low-carbon infrastructure. Lobbying groups in the US, for example, are using regulatory tools to block geothermal, solar, and wind facilities. Providing sub...
CGD NOTES
December 14, 2022
Almost a year after two oral antiviral treatments received emergency use authorization, demand is extremely low. In this note, we argue that governments and their donor partners should use data and evidence to consider the economic and clinical rationale for registering, financing, purchasing, and d...